Pharmaceutical Research Insight

Over the next decade, the fragmented antibacterials market will shift away from a blockbuster-business model, as generic erosion of market leaders and increased competition between new hospital drugs will trigger a decline in sales of branded antibacterials.

DecisionView Inc., a leading provider of software solutions to optimize clinical trial enrollment for life sciences companies, today announced the release of StudyOptimizer 4.3, the latest version of the company's flagship solution for patient enrollment planning, tracking and forecasting.

The National Comprehensive Cancer Network(R)'s (NCCN(R)'s) Oncology Research Program (ORP) recently awarded research grants to investigators following a review of proposals submitted in response to the NCCN Axitinib Request for Proposals